Benchmark maintains a Speculative Buy rating and $8 price target on Heartbeam (BEAT) shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAT:
- HeartBeam upgraded to Buy from Speculative Buy at Benchmark
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright
- HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
- Why Is HeartBeam Stock (BEAT) Up Today?